Neonatal adenoviral infection: A seventeen year experience and review of the literature

Andrea Ronchi, Christopher Doern, Evangeline Brock, Lorenza Pugni, Pablo J. Sánchez

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Objectives To describe the clinical manifestations and short-term outcomes of adenoviral infections in neonates and review all published cases to better determine impact and treatment outcomes. Study design Retrospective cohort study of all neonates hospitalized at Children's Medical Center (CMC) and Parkland Memorial Hospital (PMH), Dallas, TX with laboratory-confirmed adenoviral infection from January 1,1995-December 31, 2012. Neonates were identified by review of the CMC Virology Laboratory's prospective database of all positive adenovirus tests performed in the inpatient and ambulatory settings, and at PMH, of a prospective neonatal database that included all neonatal intensive care unit admissions. Patients also were identified by discharge International Classification of Disease, 9th edition codes for adenoviral infection. The medical records were reviewed, and a review of the English literature was performed. Results During 17 years, 26 neonates had adenoviral infection (25, CMC; 1, PMH). The principle reasons for hospitalization were respiratory signs (88%) and temperature instability (65%). Five (19%) had disseminated disease and 4 (80%) of these infants died. Ribavirin or cidofovir treatment, as well as immune globulin intravenous, did not improve outcomes except in 1 neonate. Literature review (n = 72) combined with our data found that disseminated infection was associated with death (68% vs 21% with localized infection, P <.001). In addition, neonates <14 days of age were more likely to have disseminated disease (44% vs 12%, P =.004) and death (48% vs 8%; P <.001). Conclusion Adenoviral infection in hospitalized neonates was associated with severe morbidity and mortality, especially when infection was disseminated and involved the respiratory tract. Development of new therapeutic strategies is needed.

Original languageEnglish (US)
JournalJournal of Pediatrics
Volume164
Issue number3
DOIs
StatePublished - Mar 2014

Fingerprint

Newborn Infant
Infection
Databases
Virology
Hospitalized Child
Ribavirin
Neonatal Intensive Care Units
Intravenous Immunoglobulins
International Classification of Diseases
Adenoviridae
Respiratory System
Medical Records
Inpatients
Hospitalization
Cohort Studies
Retrospective Studies
Morbidity
Temperature
Mortality
Therapeutics

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Neonatal adenoviral infection : A seventeen year experience and review of the literature. / Ronchi, Andrea; Doern, Christopher; Brock, Evangeline; Pugni, Lorenza; Sánchez, Pablo J.

In: Journal of Pediatrics, Vol. 164, No. 3, 03.2014.

Research output: Contribution to journalArticle

Ronchi, Andrea ; Doern, Christopher ; Brock, Evangeline ; Pugni, Lorenza ; Sánchez, Pablo J. / Neonatal adenoviral infection : A seventeen year experience and review of the literature. In: Journal of Pediatrics. 2014 ; Vol. 164, No. 3.
@article{35d0fbbe558240618257d3a79cecc279,
title = "Neonatal adenoviral infection: A seventeen year experience and review of the literature",
abstract = "Objectives To describe the clinical manifestations and short-term outcomes of adenoviral infections in neonates and review all published cases to better determine impact and treatment outcomes. Study design Retrospective cohort study of all neonates hospitalized at Children's Medical Center (CMC) and Parkland Memorial Hospital (PMH), Dallas, TX with laboratory-confirmed adenoviral infection from January 1,1995-December 31, 2012. Neonates were identified by review of the CMC Virology Laboratory's prospective database of all positive adenovirus tests performed in the inpatient and ambulatory settings, and at PMH, of a prospective neonatal database that included all neonatal intensive care unit admissions. Patients also were identified by discharge International Classification of Disease, 9th edition codes for adenoviral infection. The medical records were reviewed, and a review of the English literature was performed. Results During 17 years, 26 neonates had adenoviral infection (25, CMC; 1, PMH). The principle reasons for hospitalization were respiratory signs (88{\%}) and temperature instability (65{\%}). Five (19{\%}) had disseminated disease and 4 (80{\%}) of these infants died. Ribavirin or cidofovir treatment, as well as immune globulin intravenous, did not improve outcomes except in 1 neonate. Literature review (n = 72) combined with our data found that disseminated infection was associated with death (68{\%} vs 21{\%} with localized infection, P <.001). In addition, neonates <14 days of age were more likely to have disseminated disease (44{\%} vs 12{\%}, P =.004) and death (48{\%} vs 8{\%}; P <.001). Conclusion Adenoviral infection in hospitalized neonates was associated with severe morbidity and mortality, especially when infection was disseminated and involved the respiratory tract. Development of new therapeutic strategies is needed.",
author = "Andrea Ronchi and Christopher Doern and Evangeline Brock and Lorenza Pugni and S{\'a}nchez, {Pablo J.}",
year = "2014",
month = "3",
doi = "10.1016/j.jpeds.2013.11.009",
language = "English (US)",
volume = "164",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Neonatal adenoviral infection

T2 - A seventeen year experience and review of the literature

AU - Ronchi, Andrea

AU - Doern, Christopher

AU - Brock, Evangeline

AU - Pugni, Lorenza

AU - Sánchez, Pablo J.

PY - 2014/3

Y1 - 2014/3

N2 - Objectives To describe the clinical manifestations and short-term outcomes of adenoviral infections in neonates and review all published cases to better determine impact and treatment outcomes. Study design Retrospective cohort study of all neonates hospitalized at Children's Medical Center (CMC) and Parkland Memorial Hospital (PMH), Dallas, TX with laboratory-confirmed adenoviral infection from January 1,1995-December 31, 2012. Neonates were identified by review of the CMC Virology Laboratory's prospective database of all positive adenovirus tests performed in the inpatient and ambulatory settings, and at PMH, of a prospective neonatal database that included all neonatal intensive care unit admissions. Patients also were identified by discharge International Classification of Disease, 9th edition codes for adenoviral infection. The medical records were reviewed, and a review of the English literature was performed. Results During 17 years, 26 neonates had adenoviral infection (25, CMC; 1, PMH). The principle reasons for hospitalization were respiratory signs (88%) and temperature instability (65%). Five (19%) had disseminated disease and 4 (80%) of these infants died. Ribavirin or cidofovir treatment, as well as immune globulin intravenous, did not improve outcomes except in 1 neonate. Literature review (n = 72) combined with our data found that disseminated infection was associated with death (68% vs 21% with localized infection, P <.001). In addition, neonates <14 days of age were more likely to have disseminated disease (44% vs 12%, P =.004) and death (48% vs 8%; P <.001). Conclusion Adenoviral infection in hospitalized neonates was associated with severe morbidity and mortality, especially when infection was disseminated and involved the respiratory tract. Development of new therapeutic strategies is needed.

AB - Objectives To describe the clinical manifestations and short-term outcomes of adenoviral infections in neonates and review all published cases to better determine impact and treatment outcomes. Study design Retrospective cohort study of all neonates hospitalized at Children's Medical Center (CMC) and Parkland Memorial Hospital (PMH), Dallas, TX with laboratory-confirmed adenoviral infection from January 1,1995-December 31, 2012. Neonates were identified by review of the CMC Virology Laboratory's prospective database of all positive adenovirus tests performed in the inpatient and ambulatory settings, and at PMH, of a prospective neonatal database that included all neonatal intensive care unit admissions. Patients also were identified by discharge International Classification of Disease, 9th edition codes for adenoviral infection. The medical records were reviewed, and a review of the English literature was performed. Results During 17 years, 26 neonates had adenoviral infection (25, CMC; 1, PMH). The principle reasons for hospitalization were respiratory signs (88%) and temperature instability (65%). Five (19%) had disseminated disease and 4 (80%) of these infants died. Ribavirin or cidofovir treatment, as well as immune globulin intravenous, did not improve outcomes except in 1 neonate. Literature review (n = 72) combined with our data found that disseminated infection was associated with death (68% vs 21% with localized infection, P <.001). In addition, neonates <14 days of age were more likely to have disseminated disease (44% vs 12%, P =.004) and death (48% vs 8%; P <.001). Conclusion Adenoviral infection in hospitalized neonates was associated with severe morbidity and mortality, especially when infection was disseminated and involved the respiratory tract. Development of new therapeutic strategies is needed.

UR - http://www.scopus.com/inward/record.url?scp=84894341966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894341966&partnerID=8YFLogxK

U2 - 10.1016/j.jpeds.2013.11.009

DO - 10.1016/j.jpeds.2013.11.009

M3 - Article

C2 - 24359940

AN - SCOPUS:84894341966

VL - 164

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 3

ER -